Is Takotsubo Syndrome's 2% Annual Recurrence Rate Reducible?

Lim, Pitt O.

doi:10.1016/j.amjcard.2023.09.061

The American Journal of Cardiology

2023

DOI: 10.1016/j.amjcard.2023.09.061

|View full text |Cite

Is Takotsubo Syndrome's 2% Annual Recurrence Rate Reducible?

Pitt O. Lim

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Is index of microvascular resistance of Sisyphean utility in Takotsubo syndrome?

Lim

2024

ESC Heart Failure

View full text Add to dashboard Cite

Figure 1 A man in his fifties with angina, diabetes, hypertension and a normal heart on echocardiogram is admitted for a functional coronary angiogram. He has a long segment of atherosclerotic disease in the proximal and mid LAD (upper panel with bolus thermodilution). The Pd/Pa, FFR, CFR, *MRR, IMR and IMR Corr are 0.81, 0.67, 2.5, *3.7, 33, and 28 consecutively. Post-stenting (lower panel with repeat bolus thermodilution), the corresponding values are 0.95, 0.87, 5.7, *7.1, 19, and 19; the raised IMR normalized and CFR doubled. This demonstrates that epicardial coronary artery disease and flow rheology influence IMR. IMR can be recalculated with coronary wedge pressure (Pw) to account for collateral circulation. However, since there are no visible collaterals and the lesion is non-critical, it is unlikely that Pw is higher than 30 mmHg, but the **IMR is still elevated at 26 using this upper value. Alternatively, IMR can be repeated in a non-culprit vessel, although this complicates the procedure. Nevertheless, given that pre-stenting CFR ≥ 2, the discordant IMR should be disregarded in practice. Bolus thermodilution indices are systematically overestimated. After all, a *seven-fold reserve range of coronary microvascular resistance is biologically implausible.

show abstract

Is index of microvascular resistance of Sisyphean utility in Takotsubo syndrome?

Lim

2024

ESC Heart Failure

View full text Add to dashboard Cite

show abstract

Angina: The Ischemic Triad

Lim

2024

The American Journal of Cardiology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Is Takotsubo Syndrome's 2% Annual Recurrence Rate Reducible?

Cited by 2 publications

References 8 publications

Is index of microvascular resistance of Sisyphean utility in Takotsubo syndrome?

Is index of microvascular resistance of Sisyphean utility in Takotsubo syndrome?

Angina: The Ischemic Triad

Contact Info

Product

Resources

About